Document Detail

Effects of blood pressure lowering in patients with acute ischemic stroke and carotid artery stenosis.
MedLine Citation:
PMID:  25472578     Owner:  NLM     Status:  Publisher    
BACKGROUND: The Scandinavian Candesartan Acute Stroke Trial (SCAST) showed no beneficial clinical effects of blood pressure lowering with the angiotensin receptor blocker candesartan in the acute phase of stroke. In the present analysis we wanted to see if the effects of blood pressure lowering are harmful in the subgroup of patients with carotid artery stenosis.
METHODS: SCAST was a randomized- and placebo-controlled, double-masked trial of 2029 patients with acute stroke and high systolic blood pressure (≥140 mmHg). Of 1733 patients with ischemic stroke 993 underwent carotid artery imaging, and the degree of stenosis was categorized as no/insignificant (0-49%, n = 806), moderate (50-69%, n = 97) or severe (≥70%, n = 90). The trial's two co-primary effect variables were the composite end-point of vascular death, stroke or myocardial infarction, and functional outcome at six-months, according to the modified Rankin Scale.
RESULTS: Among patients with moderate or severe carotid artery stenosis the vascular end-point occurred in 9 of 87 patients (10·3%) treated with candesartan and in 17 of 100 controls (17·0%), and there was no evidence of a different risk in patients with severe stenosis (adjusted hazard ratio 0·74, 95% confidence interval 0·28-1·96, P = 0·54). For functional outcome there was also no clear difference, although in patients with severe stenosis the risk of a poor outcome was somewhat higher than in any of the other groups (adjusted odds ratio 2·24, 95% confidence interval 0·71-7·09, P = 0·16). Progressive stroke also occurred more often in patients with carotid artery stenosis treated with candesartan (10 of 87 patients (11·5%) vs. 4 of 100 patients (4·0%)), with a trend towards an increased risk with increasing severity of stenosis (P-value for linear trend = 0·04).
CONCLUSIONS: There is no clear evidence that the effect of candesartan is qualitatively different in patients with carotid artery stenosis, but there are signals that patients with severe stenosis are at particularly high risk of stroke progression and poor functional outcome.
Mirza Jusufovic; Else Charlotte Sandset; Philip M W Bath; Björn W Karlson; Eivind Berge;
Related Documents :
7568658 - Psychosocial effects of enhanced external counterpulsation in the angina patient.
4046648 - Coronary arterial lesions in mg-deficient hamsters.
6120578 - The role of coronary artery spasm in anginal syndromes.
8744178 - Spontaneous coronary artery spasm documented in a young woman. a case report.
7110468 - Platelet counts in blood taken from femoral artery, femoral vein, cubital vein, and art...
11887948 - Low-grade siderotic dysplastic nodules: determination of premalignant lesions on the ba...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-12-3
Journal Detail:
Title:  International journal of stroke : official journal of the International Stroke Society     Volume:  -     ISSN:  1747-4949     ISO Abbreviation:  Int J Stroke     Publication Date:  2014 Dec 
Date Detail:
Created Date:  2014-12-4     Completed Date:  -     Revised Date:  2014-12-5    
Medline Journal Info:
Nlm Unique ID:  101274068     Medline TA:  Int J Stroke     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2014 World Stroke Organization.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Lower Plasma Sodium Is Associated with a Microinflammatory State among Patients with Advanced Chroni...
Next Document:  Assessing novel prognostic serum biomarkers in advanced pancreatic cancer: the role of CYFRA 21-1, s...